Comparison of the effects of different percentages of soy protein in the diet on patients with type 2 diabetic nephropathy: systematic reviews and network meta-analysis.
Study Goal
The researchers aimed to determine whether the percentage of soy protein (SP) intake affects renal function and glucose/lipid metabolism in patients with type 2 diabetic nephropathy (T2DN).
Results Summary
A 35% SP diet was most effective in improving renal function markers (e.g., 24hUTP, Scr, BUN, GFR) and glycolipid metabolism (e.g., CHO, LDL-C) compared to 0% SP, though heterogeneity and bias concerns were noted. Both 35% and 100% SP diets outperformed no SP in T2DN patients.
Population
Patients with type 2 diabetic nephropathy (T2DN).
Effective Dosage
35% and 100% SP diets (percentage of total protein intake).
Duration
Not specified in the abstract.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
35% SP diet | decrease | serum creatinine (Scr) | patients with type 2 diabetic nephropathy (T2DN) | - | was the most effective | #1 |
35% SP diet | decrease | blood urea nitrogen (BUN) | patients with type 2 diabetic nephropathy (T2DN) | - | was the most effective | #2 |
35% SP diet | decrease | 24-h urine total protein (24hUTP) | patients with type 2 diabetic nephropathy (T2DN) | -154.00 (95% confidence interval: -266.69, -41.31) | was the most effective | #3 |
35% SP diet | increase | glomerular filtration rate (GFR) | patients with type 2 diabetic nephropathy (T2DN) | - | was the most effective | #4 |
35% SP diet | decrease | cholesterol (CHO) | patients with type 2 diabetic nephropathy (T2DN) | -0.55 (95% confidence interval: -1.08, -0.03) | demonstrated superior efficacy | #5 |
35% SP diet | increase | high-density lipoprotein cholesterol (HDL-C) | patients with type 2 diabetic nephropathy (T2DN) | - | demonstrated superior efficacy | #6 |
35% SP diet | decrease | low-density lipoprotein cholesterol (LDL-C) | patients with type 2 diabetic nephropathy (T2DN) | -17.71 (95% confidence interval: -39.67, -4.24) | demonstrated superior efficacy | #7 |
35% SP diet | decrease | fasting blood glucose (FPG) | patients with type 2 diabetic nephropathy (T2DN) | - | demonstrated superior efficacy | #8 |
35% SP diet | decrease | weight | patients with type 2 diabetic nephropathy (T2DN) | - | demonstrated superior efficacy | #9 |
35% SP diet | improve | renal function | patients with T2DN | - | are more effective | #10 |
35% SP diet | improve | glucolipid metabolism | patients with T2DN | - | are more effective | #11 |
100% SP diet | improve | renal function | patients with T2DN | - | are more effective | #12 |
100% SP diet | improve | glucolipid metabolism | patients with T2DN | - | are more effective | #13 |
BACKGROUND: Dietary soy protein (SP) is a potential intervention for protecting the kidneys and improving glucose and lipid metabolism. However, whether this effect is related to the percentage of SP intake remains unclear. OBJECTIVE: This study aims to review and analyze the results of randomized clinical trials (RCTs) in patients with type 2 diabetic nephropathy (T2DN) who received diets with different percentages of SP. METHODS: The databases: PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, China National Knowledge Infrastructure (CNKI), Chinese BioMedical Literature Database (CBM), WanFang, Weipu (VIP), and ClinicalTrials.gov were searched until February 2023, for RCTs on T2DN and SP. RESULTS: A total of six studies comprising 116 participants were included. The interventions were classified as 0% SP, 35% SP, and 100% SP. To improve serum creatinine (Scr), blood urea nitrogen (BUN), 24-h urine total protein (24hUTP), and glomerular filtration rate (GFR), a 35% SP diet was the most effective, compared to a 0% SP diet, which showed a mean difference of -154.00 (95% confidence interval: -266.69, -41.31) for 24hUTP. Although it had significant benefits for 24hUTP, great heterogeneity was observed. To improve the glycolipid metabolism-related markers such as cholesterol (CHO), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FPG), and weight, the 35% SP diet demonstrated superior efficacy compared to the 0% SP diet. Specifically, the mean difference for CHO was -0.55 (95% confidence interval: -1.08, -0.03), and for LDL-C, it was -17.71 (95% confidence interval: -39.67, -4.24). The other indicators were not statistically significant. Most studies had concerns regarding the risk of bias. CONCLUSION: The findings of this study demonstrate that both 35% and 100% SP diets are more effective than a diet with no SP in improving renal function and glucolipid metabolism in patients with T2DN. As a result, a diet incorporating 35% SP may be the optimal choice for individuals with T2DN. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=352638, identifier CRD42022352638.